nocodazole and curcumin

nocodazole has been researched along with curcumin in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bala, V; Chaturvedi, S; Gupta, G; Gupta, S; Konwar, R; Maikhuri, JP; Mandalapu, D; Saini, KS; Sharma, V; Sharma, VL; Thakur, S; Wahajuddin, M; Yaseen Malik, M1
Chada, S; Kawabe, S; Meyn, RE; Munshi, A; Nishikawa, T; Roth, JA1

Other Studies

2 other study(ies) available for nocodazole and curcumin

ArticleYear
Synthesis and biological evaluation of some novel triazole hybrids of curcumin mimics and their selective anticancer activity against breast and prostate cancer cell lines.
    Bioorganic & medicinal chemistry letters, 2016, 09-01, Volume: 26, Issue:17

    Topics: Antineoplastic Agents; Apoptosis; bcl-2-Associated X Protein; Breast Neoplasms; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Click Chemistry; Curcumin; Down-Regulation; Drug Screening Assays, Antitumor; Female; Half-Life; HEK293 Cells; Humans; Male; Membrane Potential, Mitochondrial; Proliferating Cell Nuclear Antigen; Prostatic Neoplasms; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-bcl-2; Triazoles

2016
Adenovirus-mediated mda-7 gene expression radiosensitizes non-small cell lung cancer cells via TP53-independent mechanisms.
    Molecular therapy : the journal of the American Society of Gene Therapy, 2002, Volume: 6, Issue:5

    Topics: Adenoviridae; Antineoplastic Agents; Apoptosis; bcl-2-Associated X Protein; Blotting, Western; Carcinoma, Non-Small-Cell Lung; Curcumin; Dose-Response Relationship, Radiation; Enzyme Inhibitors; fas Receptor; G2 Phase; Gene Transfer Techniques; Genes, Tumor Suppressor; Humans; Interleukins; Lung Neoplasms; Mitosis; Nocodazole; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Proto-Oncogene Proteins c-jun; Radiation Tolerance; Transfection; Tumor Cells, Cultured; Tumor Suppressor Protein p53; Up-Regulation

2002